These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 9554316

  • 21. New antidepressants in the treatment of neuropathic pain. A review.
    Mattia C, Paoletti F, Coluzzi F, Boanelli A.
    Minerva Anestesiol; 2002 Mar; 68(3):105-14. PubMed ID: 11981519
    [Abstract] [Full Text] [Related]

  • 22. [1+1 or 2x1? Another form of dual antidepressive mechanism of action].
    Lakatos L, Rihmer Z.
    Neuropsychopharmacol Hung; 2005 Sep; 7(3):118-24. PubMed ID: 16493875
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
    Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ.
    Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antidepressants and the risk of hyponatremia: a class-by-class review of literature.
    De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG.
    Psychosomatics; 2014 Apr; 55(6):536-47. PubMed ID: 25262043
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
    Stahl SM.
    J Clin Psychiatry; 1998 Apr; 59 Suppl 18():23-9. PubMed ID: 9840195
    [Abstract] [Full Text] [Related]

  • 32. Nefazodone and venlafaxine: two new agents for the treatment of depression.
    Goldberg RJ.
    J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069
    [Abstract] [Full Text] [Related]

  • 33. Synaptic effects of antidepressants.
    Richelson E.
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):1S-7S; discussion 7S-9S. PubMed ID: 8784643
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W, Kucia K.
    Wiad Lek; 2007 Jun; 60(1-2):28-33. PubMed ID: 17607965
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Norepinephrine involvement in antidepressant action.
    Frazer A.
    J Clin Psychiatry; 2000 Jun; 61 Suppl 10():25-30. PubMed ID: 10910014
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 Jun; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 40. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG, Cold JA, Jann MW.
    Pharmacotherapy; 1997 Jun; 17(3):511-30. PubMed ID: 9165554
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.